Bonora et al. compared the association of atrial fibrillation with SGLT2 inhibitors and other antidiabetic medications, highlighting a higher frequency of AF in patients treated with diabetes medication other than SGLT2 inhibitors [24]. Here, SLC5A2 is linked to diabetes mellitus.